Dr Mercola

STORY AT-A-GLANCE August 31, 2022, the U.S. Food and Drug Administration authorized the reformulated mRNA COVID bivalent boosters, and they didn’t even allow members of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to meet, discuss or vote on the matter The CDC’s Advisory Committee on Immunization Practices (ACIP) met for eight hours September 1, 2022, and authorized the untested boosters 13-to-1. CDC director Rochelle Walensky endorsed the recommendation later that evening Pfizer’s new booster is a bivalent injection targeting Omicron subvariants BA.4 and BA.5, which are the two currently in circulation, while Moderna’s shot targets the already extinct Wuhan strain and Omicron subvariant BA.1 The bivalent boosters will only be available to those who have already received the primary two-dose series and/or a monovalent booster at least two months ago Pfizer’s bivalent booster was tested on a total of eight mice, and they only checked antibody levels, even though antibodies cannot tell you whether the shot actually protects against infection and symptomatic and/or serious illness. Moderna also used mice to ascertain antibody responses, but has not disclosed the number of mice used